A new Northwestern Medicine study published in the Proceedings of the National Academy of Sciences has explored the impacts ...

Spinal cord injury (SCI) leads to devastating and often irreversible loss of sensory and motor function due to the limited regenerative capacity of the ...

Ultium Cells has begun producing LFP battery cells in Spring Hill, Tennessee, expanding beyond EVs to support U.S.-made ...

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

GTCR is running a continuation vehicle process for a wireless carrier it acquired five years ago, Secondaries Investor has learned. The Chicago-based private equity firm has launched a single-asset CV ...

An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...

11Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Sloan Kettering Institute for Cancer Research, New York, New York.

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

Cell reprogramming — the technique of returning adult cells to a more youthful state using four genetic factors identified in Nobel Prize-winning research — has become the buzziest approach in ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...

Plus: SpaceX has officially delivered the largest IPO in history. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...